Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
- Published Article
Clinical and experimental rheumatology
- Publication Date
Jan 01, 2001
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/11326471